Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 15

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 15
---
  $325 

 12Table of Contents

  Nine Months Ended   September 30,   2025  2024        Research and development      Employee compensation $743  $625 Stock-based compensation  331   209 Professional fees  3,466   3,483 Other research and development (b)  (10)  (800)Total research and development $4,530  $3,517  (a)Consists of investor relations, travel and other office expenses.(b)Consists of supplies and other items used in research and development activities.

NOTE 4 – DIGITAL ASSETS The Company’s digital asset holdings as of September 30, 2025 and December 31, 2024 consist of the following:    As of September 30, 2025   As of December 31, 2024   Units  Cost Basis  Fair Value  Units  Cost Basis  Fair Value Solana (SOL) 1,524.69  $250  $325   -  $-  $-        250   325       -   -  The following represents the movement of the fair value of the Company’s digital asset holdings:   Solana (SOL) December 31, 2024 $- Purchase of digital assets  250 Change in fair value  75 September 30, 2025 $325 

NOTE 5 – RELATED PARTY TRANSACTIONS During the nine months ended September 30, 2025, and 2024, a company owned by the Senior Vice President, European Operations, provided consulting services totaling $14 and $7, respectively. As of September 30, 2025, and December 31, 2024, there was $1 and $1, outstanding, respectively. During the nine months ended September 30, 2025, and 2024, a company significantly influenced by a director of a subsidiary of the Company provided professional services totaling $71 and $87, respectively. As of September 30, 2025, and December 31, 2024, there was $24 and $36 outstanding, respectively. During the nine months ended September 30, 2025, and 202